Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Safety and Efficacy of Olokizumab in a Phase III Trial of Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate-CREDO1 Study Nasonov, E., Fatenejad, S., Korneva, E., Krechikova, D., Maslyansky, A., Plaksina, T., Stanislav, M., Stoilov, R., Tyabut, T., Yakushin, S., Zonova, E., Genovese, M. WILEY. 2019
View details for Web of Science ID 000507466905171